Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)

M. Patricia Hidalgo; Carlos A. Celis; Maria Ximena Rojas-Reyes; Rodolfo J. Dennis

doi:10.1002/14651858.CD012100

Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)

M. Patricia Hidalgo
, Carlos A. Celis
, Maria Ximena Rojas-Reyes
, Rodolfo J. Dennis

Producción: Contribución a una revista › Artículo de revisión › revisión exhaustiva

Resumen

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness and safety of once-daily LABA/ICS in a combined inhaler versus once/twice-daily LABA for the treatment of COPD.

Idioma original	Inglés
Número de artículo	CD012100
Publicación	Cochrane Database of Systematic Reviews
Volumen	2016
N.º	2
DOI	https://doi.org/10.1002/14651858.CD012100
Estado	Publicada - 29 feb. 2016
Publicado de forma externa	Sí

Acceder al documento

10.1002/14651858.CD012100

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{d9bc72ba13ca4340a738105eea18abd0,

title = "Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness and safety of once-daily LABA/ICS in a combined inhaler versus once/twice-daily LABA for the treatment of COPD.",

author = "\{Patricia Hidalgo\}, M. and Celis, \{Carlos A.\} and Rojas-Reyes, \{Maria Ximena\} and Dennis, \{Rodolfo J.\}",

note = "Publisher Copyright: {\textcopyright} 2016 The Cochrane Collaboration. Published by John Wiley \& Sons, Ltd.",

year = "2016",

month = feb,

day = "29",

doi = "10.1002/14651858.CD012100",

language = "English",

volume = "2016",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "2",

}

Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD). / Patricia Hidalgo, M.; Celis, Carlos A.; Rojas-Reyes, Maria Ximena et al.
En: Cochrane Database of Systematic Reviews, Vol. 2016, N.º 2, CD012100, 29.02.2016.

Producción: Contribución a una revista › Artículo de revisión › revisión exhaustiva

TY - JOUR

T1 - Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)

AU - Patricia Hidalgo, M.

AU - Celis, Carlos A.

AU - Rojas-Reyes, Maria Ximena

AU - Dennis, Rodolfo J.

PY - 2016/2/29

Y1 - 2016/2/29

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness and safety of once-daily LABA/ICS in a combined inhaler versus once/twice-daily LABA for the treatment of COPD.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness and safety of once-daily LABA/ICS in a combined inhaler versus once/twice-daily LABA for the treatment of COPD.

UR - https://www.scopus.com/pages/publications/84961960801

U2 - 10.1002/14651858.CD012100

DO - 10.1002/14651858.CD012100

M3 - Review article

AN - SCOPUS:84961960801

SN - 1465-1858

VL - 2016

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 2

M1 - CD012100

ER -

Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)

Resumen

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto